EA201891975A1 - Тиазолидные соединения для лечения вирусных инфекций - Google Patents

Тиазолидные соединения для лечения вирусных инфекций

Info

Publication number
EA201891975A1
EA201891975A1 EA201891975A EA201891975A EA201891975A1 EA 201891975 A1 EA201891975 A1 EA 201891975A1 EA 201891975 A EA201891975 A EA 201891975A EA 201891975 A EA201891975 A EA 201891975A EA 201891975 A1 EA201891975 A1 EA 201891975A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
tiazolid
treatment
viral infections
tizoxanide
Prior art date
Application number
EA201891975A
Other languages
English (en)
Other versions
EA036505B1 (ru
Inventor
Жан-Франсуа Россиньоль
Мария Габриэлла Санторо
Original Assignee
Ромарк Лабораториз Л.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ромарк Лабораториз Л.С. filed Critical Ромарк Лабораториз Л.С.
Publication of EA201891975A1 publication Critical patent/EA201891975A1/ru
Publication of EA036505B1 publication Critical patent/EA036505B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Тиазолидные соединения, такие как нитазоксанид и/или тизоксанид, можно применять против вирусов, принадлежащих к семействам Picornaviridae или Paramyxoviridae.
EA201891975A 2016-03-31 2017-03-30 Способ лечения заболевания или состояния, вызванного вирусом, принадлежащим к роду enterovirus EA036505B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662316463P 2016-03-31 2016-03-31
PCT/US2017/024976 WO2017173056A1 (en) 2016-03-31 2017-03-30 Thiazolide compounds for treating viral infections

Publications (2)

Publication Number Publication Date
EA201891975A1 true EA201891975A1 (ru) 2019-03-29
EA036505B1 EA036505B1 (ru) 2020-11-18

Family

ID=58530692

Family Applications (2)

Application Number Title Priority Date Filing Date
EA202091849A EA202091849A1 (ru) 2016-03-31 2017-03-30 Тиазолидные соединения для лечения вирусных инфекций
EA201891975A EA036505B1 (ru) 2016-03-31 2017-03-30 Способ лечения заболевания или состояния, вызванного вирусом, принадлежащим к роду enterovirus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA202091849A EA202091849A1 (ru) 2016-03-31 2017-03-30 Тиазолидные соединения для лечения вирусных инфекций

Country Status (26)

Country Link
US (2) US11135202B2 (ru)
EP (2) EP3677282A1 (ru)
JP (2) JP6567781B2 (ru)
KR (3) KR20210035339A (ru)
CN (1) CN108289961A (ru)
AU (2) AU2017244145B2 (ru)
BR (1) BR112018069974A2 (ru)
CA (2) CA3019326C (ru)
CY (1) CY1123221T1 (ru)
DK (1) DK3436074T3 (ru)
EA (2) EA202091849A1 (ru)
ES (1) ES2810303T3 (ru)
HK (1) HK1250945A1 (ru)
HR (1) HRP20201261T1 (ru)
HU (1) HUE050601T2 (ru)
IL (2) IL262018A (ru)
LT (1) LT3436074T (ru)
MX (1) MX2021004464A (ru)
PH (1) PH12018502058A1 (ru)
PL (1) PL3436074T3 (ru)
PT (1) PT3436074T (ru)
SG (1) SG11201808453UA (ru)
SI (1) SI3436074T1 (ru)
UA (1) UA126114C2 (ru)
WO (1) WO2017173056A1 (ru)
ZA (1) ZA201806644B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111012778B (zh) * 2018-10-10 2022-06-24 北京市农林科学院 Nitazoxanide在抑制犬细小病毒中的应用
CN109536460A (zh) * 2018-12-07 2019-03-29 中国医学科学院医学生物学研究所 一种cv-a10病毒毒种及其人用灭活疫苗
CN110787161B (zh) * 2019-09-19 2022-09-27 中山大学 噻唑类化合物用于抗鱼类病毒的新用途
CN111012788B (zh) * 2019-12-12 2021-01-15 武汉职业技术学院 硝唑尼特和替唑尼特在制备抗猪繁殖与呼吸综合征病毒药物中的应用
JP2023537237A (ja) 2020-07-20 2023-08-31 ロマーク ラボラトリーズ，リミティド カンパニー チゾキサニドおよび２－ヒドロキシ－ｎ－（５－クロロ－１，３－チアゾル－２－イル）ベンズアミド（ｒｍ－４８４８）とエタノールアミン、モルホリン、プロパノールアミン、ピペラジン、およびｎ－メチルピペラジンの結晶塩
CA3189487A1 (en) 2020-08-24 2023-03-03 Jean-Francois Rossignol Use of thiazolides against coronaviruses
CA3219500A1 (en) * 2021-05-28 2022-12-01 Theodore HENDERSON Treatment using an antiviral compound and nitazoxanide
TW202327621A (zh) 2021-09-15 2023-07-16 大陸商南京強新生物醫藥有限公司 治療冠狀病毒感染的新聯用藥物、藥物組合物及其用途
CN114404439B (zh) * 2022-02-11 2023-07-11 山东农业大学 抑制不同类型猪繁殖与呼吸综合症病毒感染的阻断剂

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1437800A (en) 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
US5387598A (en) 1994-04-13 1995-02-07 Rossignol; Jean-Francois Composition and galenic formulation suitable for combatting affections of the lower abdomen
MX9604483A (es) 1994-09-08 1998-02-28 Jean-Francois Rossignol Derivados de benzamida, composiciones que contienen dicho derivado y uso de las mismas.
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
US5859038A (en) 1994-09-08 1999-01-12 Romark Laboratories, L.C. Method for treatment of helicobacter pylori infections
US5856348A (en) 1994-09-08 1999-01-05 Romark Laboratories, L.C. Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
US5965590A (en) 1994-09-08 1999-10-12 Romark Lab Lc Method for treatment of opportunistic infections with pharmaceutical compositions of tizoxanide and nitazoxanide
US5935591A (en) 1998-01-15 1999-08-10 Romark Laboratories, L.C. Method for treatment of equine protozoal myeloencephalitis with thiazolides
JP2007526208A (ja) 2003-04-11 2007-09-13 メディミューン，インコーポレーテッド 呼吸器の症状を治療又は予防する方法
UA90864C2 (en) 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
US20060194853A1 (en) 2004-10-08 2006-08-31 Rossignol Jean F Alkyl benzamides
ES2422556T3 (es) 2006-01-09 2013-09-12 Romark Lab Lc Tratamiento de hepatitis vírica
CA2695517C (en) 2007-08-03 2016-09-20 J. Edward Semple Alkylsulfonyl-substituted thiazolide compounds
GB0716292D0 (en) * 2007-08-21 2007-09-26 Biofocus Dpi Ltd Imidazopyrazine compounds
BRPI1007945C8 (pt) 2009-02-13 2021-05-25 Romark Laboratories Lc formulação farmacêutica de liberação controlada de nitazoxanida, tizoxanida ou uma combinação dos mesmos, e, comprimido de bicamada para administração oral
CN105853415A (zh) 2009-05-12 2016-08-17 罗马克实验室有限公司 卤代烷基杂芳基苯甲酰胺化合物
JP5932640B2 (ja) 2009-06-26 2016-06-08 ロマーク ラボラトリーズ エル．シー． インフルエンザを治療するための化合物および方法
US8796273B2 (en) * 2010-06-25 2014-08-05 Biota Scientific Management Pty Ltd Compound for the treatment of enteroviruses
WO2012061190A1 (en) 2010-11-01 2012-05-10 Romark Laboratories L.C. Alkylsulfinyl-substituted thiazolide compounds
EA024063B1 (ru) 2011-05-16 2016-08-31 Ромарк Лабораториз Л.С. Способ стимуляции иммунного ответа путем введения тиазолидных соединений
WO2013136495A1 (ja) 2012-03-15 2013-09-19 トヨタ自動車株式会社 車両走行制御装置
TW201524990A (zh) * 2013-10-11 2015-07-01 Alios Biopharma Inc 經取代之核苷、核苷酸及其類似物
WO2016044656A1 (en) * 2014-09-17 2016-03-24 Ansun Biopharma, Inc. Treatment of infection by human enterovirus d68
AU2015346413B2 (en) 2014-11-11 2019-08-29 Romark Laboratories, L.C. Compositions and methods of treatment with prodrugs of tizoxanide, an analogue or salt thereof

Also Published As

Publication number Publication date
HRP20201261T1 (hr) 2021-02-05
JP6567781B2 (ja) 2019-08-28
PT3436074T (pt) 2020-08-21
IL262018A (en) 2018-10-31
US11135202B2 (en) 2021-10-05
KR20180124970A (ko) 2018-11-21
CY1123221T1 (el) 2021-10-29
CN108289961A (zh) 2018-07-17
CA3019326C (en) 2021-05-25
US20220125767A1 (en) 2022-04-28
SG11201808453UA (en) 2018-10-30
EP3436074A1 (en) 2019-02-06
JP2019510044A (ja) 2019-04-11
PL3436074T3 (pl) 2020-11-02
SI3436074T1 (sl) 2020-09-30
WO2017173056A1 (en) 2017-10-05
EP3677282A1 (en) 2020-07-08
KR102136803B1 (ko) 2020-07-22
PH12018502058A1 (en) 2019-06-24
US20170281603A1 (en) 2017-10-05
KR20210035339A (ko) 2021-03-31
KR102233826B1 (ko) 2021-03-31
UA126114C2 (uk) 2022-08-17
CA3113354A1 (en) 2017-10-05
EA202091849A1 (ru) 2020-12-11
EA036505B1 (ru) 2020-11-18
HUE050601T2 (hu) 2020-12-28
IL280327A (en) 2021-03-01
MX2021004464A (es) 2021-06-04
AU2017244145B2 (en) 2019-08-01
AU2019236602A1 (en) 2019-10-17
BR112018069974A2 (pt) 2019-01-29
EP3436074B1 (en) 2020-06-10
AU2017244145A1 (en) 2018-11-15
DK3436074T3 (da) 2020-08-03
ZA201806644B (en) 2021-02-24
KR20180125552A (ko) 2018-11-23
JP2019203014A (ja) 2019-11-28
LT3436074T (lt) 2020-09-25
CA3019326A1 (en) 2017-10-05
ES2810303T3 (es) 2021-03-08
HK1250945A1 (zh) 2019-01-18

Similar Documents

Publication Publication Date Title
EA201891975A1 (ru) Тиазолидные соединения для лечения вирусных инфекций
EA201791460A1 (ru) N4-гидроксицитидин и связанные с ним производные и варианты противовирусного применения
PH12017500207B1 (en) Indoles for use in influenza virus infection
PH12016501254A1 (en) Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
EA201691726A1 (ru) Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
CL2016000493A1 (es) Inhibidores de polimerasa hcv.
EA201690979A1 (ru) Производные азепана и способы лечения инфекций гепатита в
EA201792069A1 (ru) Производные азокана и азонана и способы лечения инфекций гепатита в
EA201691440A1 (ru) Производные азепана и способы лечения инфекций гепатита в
EA201890204A1 (ru) Антибактериальные соединения
EA201791515A1 (ru) Соединения пиразина для лечения инфекционных заболеваний
CL2015003298A1 (es) Novedosas heteroarildihidropirimidinas unidas por puentes en 6 para el tratamiento y la profilaxis de infeccion por el virus de la hepatitis b
EA201990044A1 (ru) Гетероциклические соединения в качестве антибактериальных средств
EA201591524A1 (ru) Производные 2-аминопиримидина для лечения вирусных инфекций
MX2018008803A (es) Pirimidinas sustituidas con arilo para su uso en la infeccion por virus influenza.
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
EA201690594A1 (ru) Состав для лечения вич-инфекции на основе атазанавира и кобицистата
PH12017500816A1 (en) Long acting pharmaceutical compositions for hepatitis c
PH12017500820A1 (en) Combination long acting compositions and methods for hepatitis c
EA201691777A1 (ru) Содержащие цианогруппу соединения азабензофурана для лечения гепатита с
TR201910305T4 (tr) Viral enfeksiyonları tedavi etmek için bileşikler.
EA201892348A1 (ru) Комбинации и способы, включающие ингибитор сборки капсида